Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.650
+0.260 (7.67%)
At close: Aug 13, 2025, 4:00 PM
3.600
-0.050 (-1.37%)
After-hours: Aug 13, 2025, 6:43 PM EDT
Voyager Therapeutics Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for Voyager Therapeutics stock ranges from a low of $8.00 to a high of $30. The average analyst price target of $14.5 forecasts a 297.26% increase in the stock price over the next year.
Price Target: $14.50 (+297.26%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Voyager Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 9 | 9 | 9 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $9 → $8 | Buy | Maintains | $9 → $8 | +119.18% | Aug 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +721.92% | Apr 8, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +228.77% | Mar 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +721.92% | Mar 13, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +173.97% | Mar 12, 2025 |
Financial Forecast
Revenue This Year
39.39M
from 80.00M
Decreased by -50.76%
Revenue Next Year
70.47M
from 39.39M
Increased by 78.89%
EPS This Year
-2.16
from -1.13
EPS Next Year
-1.71
from -2.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 66.9M | 168.0M | 129.0M | ||
| Avg | 39.4M | 70.5M | 72.9M | ||
| Low | 9.3M | 9.3M | 9.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -16.3% | 326.3% | 83.0% | ||
| Avg | -50.8% | 78.9% | 3.5% | ||
| Low | -88.4% | -76.4% | -86.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.66 | -0.41 | -0.84 | ||
| Avg | -2.16 | -1.71 | -1.52 | ||
| Low | -2.89 | -2.85 | -2.04 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.